UBS Group’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
– Sell
-300
Closed -$4K – 10390
2013
Q4
$4K Hold
300
– – ﹤0.01% 9676
2013
Q3
$5K Sell
300
-6,400
-96% -$94.9K ﹤0.01% 9377
2013
Q2
$78K Hold
6,700
– – ﹤0.01% 6191

Other funds holding AMED

UBS Group's AMED Position: Q3 2025 in Review

UBS Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 878,850 shares — an estimated $86.5M sold.

UBS Group first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $86.5M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • UBS Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • UBS Group sold 878,850 Amedisys shares in Q3 2025, an estimated $86.5M.
  • UBS Group first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • UBS Group's Amedisys position peaked at $86.5M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.